News articles for Celgene Corporation:
Thursday, January 26, 2012
Celgene Reports Record Fourth Quarter and Full Year 2011 Operating and Financial Results
Celgene Corporation (NASDAQ: CELG) reported Non-GAAP net product sales
of $1,241 million for the fourth quarter of 2011, a 21 percent increase
from the same period in 2010. ...
read moreCelgene to Acquire Avila Therapeutics
Celgene Corporation (NASDAQ: CELG) and Avila Therapeutics, Inc., a
privately held biotechnology company developing targeted covalent drugs
that treat diseases through protein silencing, today announced a
...
read more Monday, January 23, 2012
CORRECTING and REPLACING Celgene Corporation Elects Dr. Richard W. Barker to Its Board of Directors
The contact information of release should read: Celgene Corporation
Investors: 908-673-9628 investors@celgene.com
or Media: 908-673-2275 media@celgene.com.
...
read moreMonday, January 9, 2012
Wednesday, December 28, 2011
Friday, November 25, 2011
Thursday, October 27, 2011
Wednesday, October 12, 2011
Wednesday, September 14, 2011
Wednesday, August 31, 2011